{"gene":"RHOA","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1989,"finding":"Human rhoH12 (RHOA) protein is a ~21 kDa GTPase; amplification of normal rhoH12 in NIH 3T3 cells reduced serum dependence, increased saturation density, and conferred tumorigenicity in nude mice, establishing that elevated wild-type RHOA expression has transforming activity.","method":"Transfection/overexpression in NIH 3T3 fibroblasts, Western immunoblot, immunoprecipitation, focus/soft-agar assays, nude mouse tumorigenicity","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct overexpression with multiple phenotypic readouts in a single study, but no mechanistic pathway defined beyond protein identity","pmids":["2501657"],"is_preprint":false},{"year":2000,"finding":"p120 catenin selectively inhibits RhoA activity in vitro and in vivo; its interaction with cadherins and its inhibition of RhoA are mutually exclusive, suggesting p120 regulates RhoA recruitment at nascent cell-cell contacts.","method":"In vitro RhoA activity assay, cell-based RhoA activity assay, co-immunoprecipitation","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro activity assay plus cell-based assay with mutual exclusivity data; two orthogonal methods in a single study","pmids":["10980705"],"is_preprint":false},{"year":2001,"finding":"cGMP-dependent protein kinase (cGK) phosphorylates RhoA at Ser188 in vitro, and constitutively active cGK blocks stress fiber formation induced by LPA or constitutively active RhoA; a Ser188Ala RhoA mutant is resistant to this inhibition, and cGK expression inhibits membrane translocation of RhoA.","method":"In vitro kinase assay, site-directed mutagenesis (Ser188Ala), cell transfection with constitutively active cGK, actin stress fiber imaging","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro phosphorylation assay plus mutagenesis plus cell-based functional rescue in a single study","pmids":["11162591"],"is_preprint":false},{"year":2001,"finding":"RhoA activity is required for polyamine-dependent intestinal epithelial cell migration; elevated intracellular Ca2+ induced by polyamines increases RhoA protein synthesis and stability, and inhibition of RhoA with C3 transferase blocks myosin II stress fiber formation and prevents cell migration.","method":"C3 transferase inhibition, RhoA activity assay, Ca2+ ionophore and chelator experiments, Western blot","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition with functional readout plus Ca2+ manipulation; single lab, two orthogonal approaches","pmids":["11245616"],"is_preprint":false},{"year":2003,"finding":"RhoA is required for cortical retraction and increased cortical rigidity during mitotic cell rounding; RhoA activity is elevated in rounded preanaphase mitotic cells, coinciding with serine/threonine phosphorylation-mediated decrease of p190RhoGAP activity; Rho-kinase mediates these RhoA effects.","method":"Dominant-negative/constitutively active RhoA expression, p190RhoGAP phosphorylation analysis, atomic force microscopy for cortical rigidity, time-lapse imaging","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (activity measurement, phosphorylation analysis, mechanical measurements) with genetic loss-of-function in single rigorous study","pmids":["12538643"],"is_preprint":false},{"year":2003,"finding":"RhoA (but not Rac or Cdc42) directly binds to the amino-terminal regulatory domain of MEKK1; this interaction requires an intact PHD domain cysteine in MEKK1; RhoA-GTP stimulates MEKK1 kinase activity toward MEK4 up to 10-fold.","method":"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis of MEKK1 PHD domain","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis plus binding assay; multiple methods in single study","pmids":["14581471"],"is_preprint":false},{"year":2004,"finding":"RhoA/ROCK signaling suppresses Sox9 expression and chondrogenesis: RhoA overexpression decreases glycosaminoglycan synthesis and Sox9 levels via repression of the Sox9 promoter, while ROCK inhibition (Y27632) has opposite effects; effects on Sox9 are mediated through cortical actin reorganization.","method":"RhoA overexpression, ROCK inhibitor (Y27632) treatment, Sox9 promoter-luciferase assay, actin cytoskeleton imaging","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter assay plus overexpression plus pharmacological inhibition, single lab","pmids":["15665004"],"is_preprint":false},{"year":2004,"finding":"RhoA overexpression in chondrogenic ATDC5 cells increases proliferation, delays hypertrophic differentiation, activates cyclin D1 transcription, and represses the collagen X promoter; dominant-negative RhoA inhibits PTH-related peptide induction of cyclin D1; ROCK inhibition partially rescues RhoA overexpression effects.","method":"RhoA overexpression, dominant-negative RhoA, ROCK inhibitor Y27632, luciferase promoter assays, alkaline phosphatase and mineralization assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays and genetic constructs, single lab","pmids":["14726536"],"is_preprint":false},{"year":2004,"finding":"RhoA activation downstream of podocalyxin (PC) requires NHERF and ezrin; full-length PC (but not the NHERF-binding-site mutant) increases RhoA activity and redistributes actin toward the apical membrane in MDCK cells; PC interacts directly with ezrin via its juxtamembrane cytoplasmic region.","method":"Stable cell lines expressing full-length vs. truncated PC, RhoA pulldown activity assay, immunofluorescence, co-immunoprecipitation/pulldown","journal":"Journal of the American Society of Nephrology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pulldown activity assay and mutant analysis, single lab, two methods","pmids":["15339978"],"is_preprint":false},{"year":2005,"finding":"RhoA activation is sufficient to stimulate β1 and β2 integrin-mediated adhesion in thymocytes; loss of Rho function impairs VCAM-1 adhesion and prevents integrin activation induced by Rac-1 and Rap1A; RhoA activity is critical for integrin-mediated thymocyte migration to chemokines.","method":"Dominant-negative RhoA expression, C3 transferase inhibition, integrin adhesion assays, migration assays","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with multiple adhesion/migration readouts, single lab","pmids":["15972668"],"is_preprint":false},{"year":2005,"finding":"RhoA activity regulates B cell receptor (BCR) signaling: BCR stimulation activates RhoA downstream of PI3K; dominant-negative RhoA and C3 toxin inhibit BCR-dependent calcium flux and cell proliferation; RhoA is required for PtdIns-4,5-P2 synthesis and PLCγ2 activation (but not PLCγ2 tyrosine phosphorylation); exogenous PtdIns-4,5-P2 restores calcium flux in RhoA-inhibited cells.","method":"Dominant-negative RhoA expression, C3 toxin, PI3K inhibitor, calcium flux assay, proliferation assay, PtdIns-4,5-P2 measurement","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple loss-of-function tools with mechanistic rescue experiment (exogenous PIP2), two orthogonal approaches","pmids":["15664190"],"is_preprint":false},{"year":2006,"finding":"Synaptopodin induces actin stress fibers by competitively blocking Smurf1-mediated ubiquitination of RhoA, thereby preventing proteasomal degradation of RhoA; gene silencing of synaptopodin causes loss of stress fibers and impairs cell migration in kidney podocytes.","method":"siRNA knockdown of synaptopodin, ubiquitination assays, RhoA degradation assays, actin imaging, migration assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic ubiquitination assay plus RNAi phenotype plus rescue, multiple orthogonal methods","pmids":["16622418"],"is_preprint":false},{"year":2007,"finding":"p66Shc mediates anoikis through RhoA activation; re-expression of p66Shc in p66Shc-null cells restores anoikis through a mechanism requiring focal adhesion targeting and RhoA activation (but not cytochrome c-binding motif); this pathway stimulates focal adhesions, stress fibers, and tension-dependent cell death upon detachment.","method":"p66Shc re-expression in knockout cells, RhoA activity assay, focal adhesion imaging, cell death assays","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined mechanistic pathway with mutant analysis and RhoA activity measurement, single lab","pmids":["17908916"],"is_preprint":false},{"year":2007,"finding":"In bovine spermatozoa, the GNA13-RhoA-ROCK2-LIMK2-cofilin signaling cascade is present; RhoA interacts with AKAP4 (identified by overlay, immunoprecipitation, and mass spectrometry); AKAP3 phosphorylation increases its interaction with PRKAR2 and ROPN1 (RhoA-interacting proteins).","method":"Western blot, overlay assay, co-immunoprecipitation, mass spectrometry, pulldown","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP and mass spectrometry for interaction identification, single lab","pmids":["17928627"],"is_preprint":false},{"year":2008,"finding":"RhoA-GDP (not RhoA-GTP) regulates RhoB protein stability via a mechanism requiring RhoGDIα; RhoGDIα is rate-limiting in basal conditions, and silencing RhoA makes RhoGDI available to stabilize RhoB; a RhoA mutant (R68E) unable to bind RhoGDIα cannot rescue RhoB up-regulation after RhoA silencing.","method":"siRNA knockdown of RhoA, RhoGDIα manipulation, half-life measurement, RhoA mutant (R68E) rescue experiment, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis plus knockdown with protein stability readout, single lab, two methods","pmids":["18524772"],"is_preprint":false},{"year":2008,"finding":"Myosin phosphatase-RhoA interacting protein (M-RIP) directly binds both RhoA and the myosin-binding subunit of myosin phosphatase in vitro, targets myosin phosphatase to the actomyosin contractile filament, and is required for RhoA/ROCK-mediated inhibition of myosin phosphatase; M-RIP silencing prevents LPA-mediated MYPT1 phosphorylation and inhibition of myosin phosphatase activity; M-RIP silencing leads to loss of stress fiber-associated RhoA.","method":"Co-immunoprecipitation, in vitro binding, siRNA knockdown, MYPT1 phosphorylation assay","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro binding plus siRNA functional assay, single lab","pmids":["17661354"],"is_preprint":false},{"year":2009,"finding":"Only activated (GTP-bound) RhoA and ROCK1 are sequestered into stress granules (SGs) during cellular stress; sequestration of activated ROCK1 in SGs prevents ROCK1 from interacting with JIP-3 and activating the JNK apoptotic pathway, protecting cells from apoptosis.","method":"Immunofluorescence, co-immunoprecipitation, stress granule fractionation, apoptosis assays","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus localization with functional consequence, single lab","pmids":["20004716"],"is_preprint":false},{"year":2009,"finding":"In mouse pancreatic acini, CCK activates RhoA specifically through Gα13 (not Gα12 or Gαq); the RGS domain of p115-RhoGEF (Gα12/13-specific inhibitor) abolishes CCK-stimulated RhoA activation.","method":"Constitutively active Gα subunit expression, RhoA and Rac1 activity assays, RGS domain inhibitor constructs","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — activity assays with specific pathway inhibitors and constitutively active constructs, single lab","pmids":["19940064"],"is_preprint":false},{"year":2010,"finding":"PLCδ3 negatively regulates RhoA protein expression; PLCδ3 knockdown prevents the differentiation-induced decrease in RhoA protein levels in Neuro2a cells; dominant-negative RhoA or ROCK inhibitor Y27632 rescues neurite extension defects caused by PLCδ3 knockdown, placing RhoA downstream of PLCδ3 in neurite outgrowth regulation.","method":"siRNA knockdown, dominant-negative RhoA, ROCK inhibitor, Western blot, neurite outgrowth assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis via rescue experiment plus protein-level measurements, single lab","pmids":["21187285"],"is_preprint":false},{"year":2011,"finding":"Citron kinase (CIT-K) acts as an upstream regulator (not downstream effector) of RhoA during late cytokinesis/abscission; CIT-K depletion displaces active RhoA and anillin from the midbody; CIT-K overexpression-induced abscission delay is reversed by RhoA inactivation; CIT-K physically interacts with anillin.","method":"CIT-K siRNA depletion, RhoA inactivation, co-immunoprecipitation (CIT-K with anillin), live-cell imaging of cytokinesis","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established by rescue experiment, physical interaction by co-IP, single lab","pmids":["21849473"],"is_preprint":false},{"year":2012,"finding":"Protein kinase D phosphorylates rhotekin (at Ser-435), an effector of RhoA; a phosphomimetic S435E rhotekin mutant increases active RhoA levels and enhances RhoA membrane anchoring, resulting in increased stress fiber formation.","method":"In vitro kinase assay, site-directed mutagenesis (S435E), RhoA activity assay, immunofluorescence","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay plus mutagenesis plus functional readout, single lab","pmids":["22228765"],"is_preprint":false},{"year":2014,"finding":"The RHOA p.Gly17Val mutant found in AITL does not bind GTP and inhibits wild-type RHOA function (dominant-negative), demonstrating that this recurrent somatic mutation causes loss of RHOA GTPase activity.","method":"GTP-binding assay, dominant-negative functional assay","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct GTP-binding assay plus dominant-negative functional assay; independently replicated in two papers (PMID 24413737 and 24584070)","pmids":["24413737","24584070"],"is_preprint":false},{"year":2014,"finding":"CD44 acts upstream of RhoA to regulate YAP expression and nuclear localization; CD44 knockdown reduces RhoA expression; constitutively active RhoA (RhoA-V14) rescues YAP reduction caused by CD44 knockdown; RhoA knockdown similarly reduces YAP, placing RhoA between CD44 and YAP in the Hippo pathway.","method":"siRNA knockdown of CD44 and RhoA, constitutively active RhoA rescue, Western blot, nuclear localization assay","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established by rescue experiment, single lab","pmids":["25101858"],"is_preprint":false},{"year":2015,"finding":"Fam65b is an atypical inhibitor of RhoA that restricts spontaneous RhoA activation in resting T lymphocytes; chemokine stimulation phosphorylates Fam65b, decreasing its affinity for RhoA and causing its translocation from plasma membrane to cytosol, thereby relieving tonic RhoA inhibition and allowing RhoA-dependent actin polymerization and T cell migration.","method":"Fam65b-deficient mouse (conditional KO), RhoA activity assay, phosphorylation analysis, intranodal migration imaging, in vitro migration assay","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO mouse with RhoA activity measurements plus phosphorylation analysis, single lab","pmids":["30254631"],"is_preprint":false},{"year":2015,"finding":"RhoA deficiency in T cells inhibits TH2 (but not TH1) differentiation, prevents allergic airway inflammation, and causes defects in glycolysis and oxidative phosphorylation; RhoA couples glycolysis to TH2 differentiation through regulation of IL-4 receptor mRNA expression and TH2-specific signaling; ROCK inhibition also blocks TH2 differentiation.","method":"Conditional RhoA knockout mice (RhoA flox/flox × CD2-Cre), metabolic assay (Seahorse XF24), cytokine measurement (ELISA, intracellular staining), in vivo allergy model","journal":"The Journal of allergy and clinical immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with multiple mechanistic readouts, single lab","pmids":["26100081"],"is_preprint":false},{"year":2015,"finding":"RhoA GTPase controls Golgi outpost (GOP) formation in dendrites via a RhoA-ROCK-LIMK1-PKD1-slingshot-cofilin-dynamin pathway that regulates tubule fission from the somatic Golgi; live-cell imaging demonstrated that GOPs are generated from somatic GA tubules, and perturbation of RhoA pathway arrests tubule fission.","method":"Live-cell imaging, confocal microscopy, pharmacological inhibition of pathway components, dominant-negative and constitutively active constructs","journal":"Current biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live imaging plus pathway dissection with multiple inhibitors, single lab","pmids":["25802147"],"is_preprint":false},{"year":2016,"finding":"In Drosophila apical constriction, a RhoA GAP (C-GAP) spatially restricts RhoA pathway activity to a central apical cortex position and is required for pulsatile actomyosin contractility; C-GAP coordinates with RhoGEF2 to drive RhoA activity cycling underlying contractile pulses; C-GAP expression level governs the transition from reversible to irreversible cell shape change.","method":"Genetic loss-of-function (C-GAP mutants), live imaging, FRET-based RhoA biosensor, epistasis analysis with RhoGEF2","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — biosensor-based activity measurements plus genetic epistasis with live imaging, multiple orthogonal methods","pmids":["27551058"],"is_preprint":false},{"year":2017,"finding":"Deletion of Kctd13 in mice elevates RhoA protein levels (consistent with KCTD13/CUL3 ubiquitin ligase targeting RhoA for degradation) and reduces synaptic transmission; pharmacological inhibition of RhoA reverses the reduced synaptic transmission phenotype.","method":"Kctd13 gene deletion (mouse KO), RhoA protein level measurement, synaptic transmission electrophysiology, RhoA inhibitor rescue","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with mechanistic rescue (RhoA inhibition reverses phenotype), RhoA protein level measurement; replicated in zebrafish","pmids":["29088697"],"is_preprint":false},{"year":2017,"finding":"Daam1 activates RhoA downstream of Wnt5a to promote glioblastoma cell invasion; siRNA knockdown of Daam1 inhibits Wnt5a-induced RhoA activation and stress fiber formation; RhoA inhibitor (CCG-1423) also blocks Wnt5a-induced invasion, placing Daam1 upstream of RhoA in Wnt5a→Daam1→RhoA→invasion pathway.","method":"siRNA knockdown, pulldown assays for Daam1 and RhoA activation, cell invasion assay, RhoA inhibitor","journal":"Oncology reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis by dual knockdown and inhibitor, RhoA activity assays, single lab","pmids":["29207169"],"is_preprint":false},{"year":2017,"finding":"RhoA promotes Schwann cell differentiation via the JNK pathway rather than ROCK; inhibition of RhoA (with C3 transferase or siRNA) activates JNK and p38 MAPK in differentiating Schwann cells; JNK inhibitor (but not p38 inhibitor) rescues SC differentiation under RhoA inhibition.","method":"siRNA knockdown, C3 transferase inhibition, ROCK inhibitor (no effect), JNK/p38 inhibitors, differentiation assays","journal":"Experimental neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis via pathway-selective inhibitors plus knockdown, single lab","pmids":["29940159"],"is_preprint":false},{"year":2017,"finding":"FKBP51 promotes RhoA activity and ROCK signaling by interacting with RhoGAPs DLC1 and DLC2 (identified by immunoprecipitation and mass spectrometry); FKBP51 overexpression increases RhoA activity and invasion, while FKBP51 depletion causes cortical actin redistribution and decreases RhoA activity and cell motility.","method":"Immunoprecipitation + mass spectrometry, RhoA activity assay, siRNA knockdown, overexpression, actin imaging","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS-validated interaction plus RhoA activity assay with loss- and gain-of-function, single lab","pmids":["28032931"],"is_preprint":false},{"year":2018,"finding":"RHOA G17V expression in CD4+ T cells induces T follicular helper (Tfh) cell specification with increased ICOS upregulation and PI3K/MAPK signaling; combined with Tet2 loss, RHOA G17V drives AITL development in mice; in vivo tumor proliferation is inhibited by ICOS/PI3K-specific blockade.","method":"Transgenic/conditional expression of Rhoa G17V in CD4+ T cells, Tet2 KO/RHOA G17V double-mutant mouse model, ICOS/PI3K inhibitor treatment, flow cytometry","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo mouse model with genetic interaction (epistasis), pathway inhibitor rescue; multiple orthogonal methods","pmids":["29398449"],"is_preprint":false},{"year":2019,"finding":"Anillin directly binds GTP-RhoA at the cortical membrane to antagonize its otherwise labile membrane association, promoting effector recruitment; anillin also concentrates membrane PIP2 to retain RhoA after it disengages from anillin; cyclic re-binding of RhoA to anillin (regulated by anillin cortical density) repeatedly resets RhoA dissociation kinetics ('kinetic scaffolding'), substantially increasing RhoA dwell time.","method":"FRAP, live-cell imaging, optogenetics, mutant analysis (anillin-RhoA binding mutants), PIP2 manipulation","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple biophysical methods (FRAP, optogenetics) with mutant validation; mechanistic model tested experimentally","pmids":["31105010"],"is_preprint":false},{"year":2019,"finding":"Optogenetic activation of RhoA in model epithelium shows: short pulses drive reversible junction contractions; longer pulses produce irreversible junction length changes; junction remodeling requires formin-mediated E-cadherin clustering and dynamin-dependent endocytosis downstream of RhoA; irreversible deformation involves thresholded tension remodeling and continuous strain relaxation.","method":"Optogenetics (pulsatile RhoA activation), live imaging, dynamin inhibitor, formin inhibitor, vertex model","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — optogenetic control with quantitative modeling and pharmacological dissection; multiple orthogonal methods","pmids":["31883774"],"is_preprint":false},{"year":2019,"finding":"ARHGAP29 induction under hypoxia suppresses RhoA activity and MRTF-A signaling, reversing myofibroblast differentiation; decreased RhoA activity under hypoxia is causally linked to reduced αSMA expression and altered contractility.","method":"Hypoxia treatment, ARHGAP29 induction measurement, RhoA activity assay, MRTF-A localization, siRNA knockdown, actin imaging","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — activity assay plus knockdown with mechanistic link to transcription factor, single lab","pmids":["30659117"],"is_preprint":false},{"year":2020,"finding":"Dectin-1 stimulation by β-glucan activates RHOA downstream of SRC family kinases (SFK, not SYK) to drive ROCK-myosin light chain (MLC) pathway, generating mechanical force/areal contraction and mediating phagocytosis of C. albicans.","method":"RHOA activity assay, SYK and SFK inhibitors, traction force microscopy, phagocytosis assay, stress fiber imaging","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — activity assay plus pathway-specific inhibitors plus functional phagocytosis assay, single lab","pmids":["31964711"],"is_preprint":false},{"year":2020,"finding":"Tension on syndecan-4 activates the kindlin-2/β1 integrin/RhoA axis in a PI3K-dependent manner to tune cell mechanics; syndecan-4 cytoplasmic variable region is indispensable for mechanical adaptation; a syndecan-4/α-actinin/F-actin scaffold assembles at the bead adhesion site.","method":"Magnetic twisting cytometry (local tension application), RhoA activity assay (GLISA), PI3K inhibitor, β1 integrin knockdown, kindlin-2 knockdown, YAP activation measurement","journal":"Nature materials","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal mechanistic assays (force application, activity assay, pathway knockdowns) with mechanistic model validated experimentally","pmids":["31907416"],"is_preprint":false},{"year":2020,"finding":"CDC42 drives RHOA activation during sperm capacitation; RHOA activation and its effect on actin polymerization begin when CDC42 reaches maximum activity; RHOA's role in capacitation and acrosomal reaction is independent of ROCK1.","method":"CDC42/RHOA inhibitors, ROCK1 inhibitor, actin polymerization kinetics assay, capacitation assay, acrosome reaction assay","journal":"Reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological epistasis plus activity assays, single lab","pmids":["32567555"],"is_preprint":false},{"year":2021,"finding":"RhoA/Cdc42 signaling is dispensable for megakaryocyte polyploidization (endomitosis) but is essential for cytoplasmic maturation and proplatelet formation; RhoA/Cdc42 double KO causes macrothrombocytopenia; the maturation defect is associated with downregulation of MLC2 and β1-tubulin, upregulation of LIMK1 and cofilin-1, and impaired MKL1/SRF signaling.","method":"Conditional RhoA/Cdc42 double-KO mice, bone marrow analyses, protein/mRNA profiling, proplatelet formation assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional double-KO with defined molecular mechanism (MKL1/SRF), multiple orthogonal readouts in single rigorous study","pmids":["33979620"],"is_preprint":false},{"year":2023,"finding":"Cardiomyocyte-specific RhoA KO mice develop dilated cardiomyopathy and enhanced senescence with impaired mitophagy; RhoA-ROCK phosphorylates N-Myc leading to its degradation and Parkin upregulation; loss of RhoA reduces Parkin, impairing mitophagy; re-expression of Parkin in RhoA-depleted cardiomyocytes rescues mitophagy and cardiac function in vitro and in vivo.","method":"Cardiomyocyte-specific RhoA conditional KO mouse, Parkin re-expression rescue, N-Myc phosphorylation analysis, mitophagy assay, cardiac function measurement (echocardiography)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with mechanistic rescue experiment (Parkin re-expression), phosphorylation analysis; multiple orthogonal methods","pmids":["36758801"],"is_preprint":false},{"year":2023,"finding":"Human TRPV4 forms a direct structural complex with RhoA, with RhoA interacting with the membrane-facing surface of TRPV4 ankyrin repeat domains; contact interface residues are mutated in neuropathies; RhoA suppresses TRPV4 channel activity; agonist (4α-PDD) causes pore opening while inhibitor (HC-067047) induces a π-to-α transition in the pore-forming helix S6.","method":"Cryo-EM structure of TRPV4-RhoA complex, functional channel assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure with defined binding interface, functionally validated by channel activity assays","pmids":["37353478"],"is_preprint":false},{"year":2023,"finding":"Conditional deletion of RhoA in osteoclast lineage causes osteopetrosis due to suppressed bone resorption; RhoA deficiency suppresses Akt-mTOR-NFATc1 signaling during osteoclast differentiation; RhoA activation in osteoclast precursors prevented OVX-induced bone loss in mice.","method":"Osteoclast-specific RhoA conditional KO mice, OVX model, bone marrow macrophage differentiation assay, Akt/mTOR/NFATc1 pathway analysis","journal":"Molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with in vivo phenotype and pathway identification, single lab","pmids":["37020186"],"is_preprint":false}],"current_model":"RHOA is a plasma-membrane-associated small GTPase that cycles between inactive GDP-bound (cytosolic, complexed with RhoGDI) and active GTP-bound (membrane-localized) states regulated by GEFs (including NET1, Ect2, RhoGEF2, Daam1), GAPs (including p190RhoGAP, C-GAP, ARHGAP29, DLC1/DLC2), GDIs, and post-translational modifications (Ser188 phosphorylation by PKA/cGK inactivates RhoA and promotes cytosolic sequestration; Tyr42 phosphorylation and Cys16/20 oxidation promote GDI dissociation); once active, RhoA drives actomyosin contractility through its principal effector ROCK (which phosphorylates MLC and inhibits myosin phosphatase via MYPT1), regulates actin polymerization and stress fiber formation, controls cytokinesis/abscission, mitotic cell rounding, epithelial junction remodeling, dendritic Golgi outpost biogenesis, Schwann cell differentiation (via JNK), B-cell receptor signaling (via PIP2/PLCγ2), TH2 differentiation (via ICOS/PI3K and glycolysis), osteoclast differentiation (via Akt-mTOR-NFATc1), cardiac mitochondrial quality control (via ROCK-N-Myc-Parkin axis), and transcriptional programs (via SRF/MRTF-A and YAP/TAZ); upstream, RHOA is activated by GPCRs (through Gα12/13), mechanical force (via integrins, syndecan-4, and cadherins), and CDC42, while being inhibited by p120 catenin, Smurf1-mediated ubiquitination (counteracted by synaptopodin), Fam65b (relieved by chemokine-induced phosphorylation), and KCTD13/CUL3 ubiquitin ligase; structurally, RhoA directly contacts TRPV4 ankyrin repeat domains (suppressing channel activity) and binds MEKK1 to stimulate its kinase activity, revealing roles beyond cytoskeletal regulation."},"narrative":{"mechanistic_narrative":"RHOA is a ~21 kDa small GTPase that cycles between inactive GDP-bound and active GTP-bound states to control actomyosin contractility, cell shape, and motility across diverse cell types [PMID:2501657, PMID:12538643]. In its active form it engages effectors to drive stress fiber and focal adhesion formation, mitotic cortical rigidity and rounding, and tension-dependent processes; its principal contractile output runs through ROCK, which sustains myosin light-chain phosphorylation by inhibiting myosin phosphatase via the scaffold M-RIP that targets the phosphatase to actomyosin filaments [PMID:12538643, PMID:17661354]. Active RHOA membrane residence is stabilized at the cortex by anillin, which binds GTP-RHOA and concentrates PIP2 to repeatedly reset its dissociation kinetics ('kinetic scaffolding'), a mechanism critical for cortical effector recruitment and cytokinesis/abscission, where citron kinase acts upstream to maintain active RHOA and anillin at the midbody [PMID:31105010, PMID:21849473]. RHOA activity is set by an extensive regulatory network: it is activated downstream of GPCRs through Gα13 and of receptors and mechanical inputs including CD44, syndecan-4/integrin/kindlin-2, podocalyxin, Dectin-1, Wnt5a-Daam1, and CDC42 [PMID:19940064, PMID:31907416, PMID:25101858, PMID:15339978, PMID:31964711, PMID:29207169, PMID:32567555], and is restrained by GAPs (C-GAP, ARHGAP29, and DLC1/2 acting through FKBP51), by p120 catenin, by the atypical inhibitor Fam65b, and by ubiquitin-mediated degradation via Smurf1 (countered by synaptopodin) and the KCTD13/CUL3 ligase [PMID:27551058, PMID:30659117, PMID:28032931, PMID:10980705, PMID:30254631, PMID:16622418, PMID:29088697]. Phosphorylation of RHOA at Ser188 by cGMP-dependent kinase inactivates it and blocks its membrane translocation [PMID:11162591]. Beyond cytoskeletal regulation, RHOA directly binds and stimulates the kinase MEKK1, contacts the TRPV4 ankyrin-repeat domain to suppress channel activity, and governs transcriptional programs through MRTF-A/SRF and the Hippo effector YAP [PMID:14581471, PMID:37353478, PMID:33979620, PMID:25101858]. Through these activities RHOA shapes specialized cellular programs including B-cell receptor signaling via PIP2/PLCγ2, TH2 differentiation, osteoclast differentiation via Akt-mTOR-NFATc1, cardiac mitochondrial quality control via a ROCK-N-Myc-Parkin axis, Schwann cell differentiation via JNK, and dendritic Golgi outpost biogenesis [PMID:15664190, PMID:26100081, PMID:37020186, PMID:36758801, PMID:29940159, PMID:25802147]. The recurrent somatic RHOA p.Gly17Val mutation, which abolishes GTP binding and acts dominant-negatively, drives angioimmunoblastic T-cell lymphoma by inducing T follicular helper specification through ICOS/PI3K signaling, particularly in cooperation with Tet2 loss [PMID:24413737, PMID:24584070, PMID:29398449].","teleology":[{"year":1989,"claim":"Established that RHOA is a ~21 kDa GTPase whose elevated wild-type expression is transforming, motivating mechanistic study of its signaling outputs.","evidence":"Overexpression in NIH 3T3 fibroblasts with focus/soft-agar and nude mouse tumorigenicity assays","pmids":["2501657"],"confidence":"Medium","gaps":["No downstream pathway defined beyond protein identity","Mechanism of transformation not resolved"]},{"year":2001,"claim":"Defined how RHOA is switched off post-translationally, showing cGMP-dependent kinase phosphorylates Ser188 to block stress fiber formation and membrane translocation.","evidence":"In vitro kinase assay, Ser188Ala mutagenesis, and actin imaging in cells","pmids":["11162591"],"confidence":"High","gaps":["Does not address how this integrates with GEF/GAP regulation in vivo","Tissue contexts where this dominates unclear"]},{"year":2003,"claim":"Showed RHOA drives mitotic cortical rigidity and rounding through ROCK and downregulation of p190RhoGAP, linking RHOA activity to cell-cycle-coupled mechanics.","evidence":"Dominant-negative/CA RhoA, p190RhoGAP phosphorylation analysis, atomic force microscopy, time-lapse imaging","pmids":["12538643"],"confidence":"High","gaps":["GEF responsible for mitotic RhoA activation not identified here","How phosphorylation suppresses p190RhoGAP unresolved"]},{"year":2003,"claim":"Revealed a non-cytoskeletal effector function: RHOA-GTP directly binds and stimulates MEKK1 kinase activity, connecting RHOA to MAPK signaling.","evidence":"Co-IP, in vitro kinase assay toward MEK4, and MEKK1 PHD-domain mutagenesis","pmids":["14581471"],"confidence":"High","gaps":["Physiological contexts for RhoA-MEKK1 coupling not established","Selectivity over Rac/Cdc42 in cells not tested in vivo"]},{"year":2005,"claim":"Connected RHOA to immune-receptor signaling, demonstrating it is required downstream of PI3K for BCR-driven PIP2 synthesis, PLCγ2 activation, and calcium flux.","evidence":"Dominant-negative RhoA, C3 toxin, PI3K inhibition, calcium flux, and exogenous PIP2 rescue","pmids":["15664190"],"confidence":"High","gaps":["The effector linking RhoA to PIP2 synthesis not identified","GEF activating RhoA downstream of BCR unknown"]},{"year":2006,"claim":"Identified ubiquitin-dependent control of RHOA abundance, showing synaptopodin stabilizes RhoA by blocking Smurf1-mediated ubiquitination to maintain stress fibers.","evidence":"siRNA knockdown, ubiquitination and degradation assays, actin/migration phenotypes in podocytes","pmids":["16622418"],"confidence":"High","gaps":["Whether Smurf1 selectively targets active vs inactive RhoA not resolved","Generality beyond podocytes untested"]},{"year":2008,"claim":"Clarified how RHOA-effector coupling to myosin phosphatase is organized in space, identifying M-RIP as a scaffold targeting myosin phosphatase to actomyosin for RhoA/ROCK-mediated inhibition.","evidence":"Co-IP, in vitro binding, siRNA knockdown, MYPT1 phosphorylation assay","pmids":["17661354"],"confidence":"Medium","gaps":["Structural basis of M-RIP binding both RhoA and MYPT1 not defined","In vivo requirement not shown"]},{"year":2014,"claim":"Established RHOA as a disease driver, showing the recurrent AITL p.Gly17Val mutant fails to bind GTP and acts dominant-negatively.","evidence":"GTP-binding and dominant-negative functional assays; replicated across two studies","pmids":["24413737","24584070"],"confidence":"High","gaps":["Cellular consequences of dominant-negative RhoA in T cells not yet defined here","Why a loss-of-function GTPase mutant is oncogenic unresolved at this stage"]},{"year":2016,"claim":"Showed how RHOA activity is spatially patterned to produce pulsatile contractility, with a GAP (C-GAP) restricting RhoA pathway activity and coordinating with RhoGEF2 to drive activity cycling during apical constriction.","evidence":"Drosophila genetic loss-of-function, FRET RhoA biosensor, live imaging, epistasis with RhoGEF2","pmids":["27551058"],"confidence":"High","gaps":["Molecular trigger initiating each pulse not defined","How GEF/GAP activities are temporally synchronized unresolved"]},{"year":2017,"claim":"Demonstrated in vivo that RHOA abundance is controlled by the KCTD13/CUL3 ligase, and that excess RhoA impairs synaptic transmission reversibly by RhoA inhibition.","evidence":"Kctd13 KO mouse, RhoA protein measurement, electrophysiology, RhoA-inhibitor rescue; replicated in zebrafish","pmids":["29088697"],"confidence":"High","gaps":["Direct ubiquitination of RhoA by KCTD13/CUL3 inferred, not shown biochemically here","Effector pathway altering synaptic transmission not defined"]},{"year":2018,"claim":"Resolved the oncogenic mechanism of RHOA G17V, showing it induces Tfh specification via ICOS/PI3K and cooperates with Tet2 loss to drive AITL in vivo.","evidence":"Conditional Rhoa G17V expression, Tet2/G17V double-mutant mice, ICOS/PI3K inhibitor treatment, flow cytometry","pmids":["29398449"],"confidence":"High","gaps":["How a GTP-binding-deficient mutant activates ICOS/PI3K mechanistically unclear","Contribution of dominant-negative versus neomorphic activity not separated"]},{"year":2019,"claim":"Defined the biophysical basis of RHOA cortical residence, showing anillin binds GTP-RhoA and concentrates PIP2 to repeatedly reset its dissociation kinetics ('kinetic scaffolding').","evidence":"FRAP, optogenetics, anillin-RhoA binding mutants, PIP2 manipulation","pmids":["31105010"],"confidence":"High","gaps":["How anillin density is regulated in vivo not addressed","Generality across non-cytokinetic contexts untested"]},{"year":2019,"claim":"Quantitatively linked RHOA activity dynamics to junction remodeling, showing pulse duration determines reversible versus irreversible deformation via formin-mediated E-cadherin clustering and dynamin endocytosis.","evidence":"Optogenetic pulsatile RhoA activation, live imaging, formin/dynamin inhibitors, vertex modeling","pmids":["31883774"],"confidence":"High","gaps":["Endogenous GEF/GAP dynamics producing such pulses not mapped","Molecular memory underlying irreversibility incompletely defined"]},{"year":2020,"claim":"Showed RHOA integrates mechanical force, identifying a syndecan-4/kindlin-2/β1 integrin/RhoA axis that tunes cell mechanics in a PI3K-dependent manner.","evidence":"Magnetic twisting cytometry, RhoA GLISA, PI3K inhibition, integrin/kindlin-2 knockdowns, YAP readout","pmids":["31907416"],"confidence":"High","gaps":["GEF converting tension into RhoA activation not identified","Coupling between RhoA and YAP downstream not mechanistically detailed here"]},{"year":2021,"claim":"Separated RHOA's roles in a developmental program, showing RhoA/Cdc42 are dispensable for megakaryocyte polyploidization but essential for cytoplasmic maturation and proplatelet formation via MKL1/SRF.","evidence":"Conditional RhoA/Cdc42 double-KO mice, protein/mRNA profiling, proplatelet assays","pmids":["33979620"],"confidence":"High","gaps":["Individual contribution of RhoA versus Cdc42 not separated","Direct SRF target genes driving maturation not defined"]},{"year":2023,"claim":"Provided a structural view of a non-canonical RHOA function, showing direct binding to the TRPV4 ankyrin-repeat domain that suppresses channel activity, with interface residues mutated in neuropathies.","evidence":"Cryo-EM structure of the TRPV4-RhoA complex and channel functional assays","pmids":["37353478"],"confidence":"High","gaps":["Whether GDP/GTP state governs the interaction not fully resolved","Physiological signaling consequence of channel suppression in neurons untested here"]},{"year":2023,"claim":"Extended RHOA function to organelle quality control, defining a cardiomyocyte RhoA-ROCK-N-Myc-Parkin axis required for mitophagy and cardiac function.","evidence":"Cardiomyocyte-specific RhoA KO, Parkin re-expression rescue, N-Myc phosphorylation analysis, mitophagy and echocardiography","pmids":["36758801"],"confidence":"High","gaps":["Direct N-Myc phosphorylation by ROCK not biochemically isolated","Whether this axis operates in non-cardiac tissues unknown"]},{"year":null,"claim":"How the full GEF/GAP/GDI network, post-translational modifications, and degradation pathways are integrated to produce the precise spatiotemporal RhoA activity patterns required by each cellular program remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No unified model linking upstream activators to context-specific effector choice (ROCK vs JNK vs MEKK1)","How loss-of-function G17V produces gain-of-function oncogenic phenotypes mechanistically unclear","Endogenous activity dynamics in most tissues not measured with biosensors"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[0,21]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[4,17,22,36]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,40]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,20,32]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[23,16]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[4,15]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[17,22,36]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[4,19]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,24,31]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[21,31]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[25,38,41]}],"complexes":[],"partners":["ROCK","MEKK1","TRPV4","ANILLIN","RHOGDI","M-RIP","RHOTEKIN","FAM65B"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P61586","full_name":"Transforming protein RhoA","aliases":["Rho cDNA clone 12","h12"],"length_aa":193,"mass_kda":21.8,"function":"(Microbial infection) Serves as a target for the yopT cysteine peptidase from Yersinia pestis, vector of the plague","subcellular_location":"Cell membrane; Cytoplasm, cytoskeleton; Cleavage furrow; Cytoplasm, cell cortex; Midbody; Cell projection, lamellipodium; Cell projection, dendrite; Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P61586/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RHOA","classification":"Not Classified","n_dependent_lines":548,"n_total_lines":1208,"dependency_fraction":0.45364238410596025},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000067560","cell_line_id":"CID000609","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":1},{"compartment":"vesicles","grade":1}],"interactors":[{"gene":"ARHGDIA","stoichiometry":10.0},{"gene":"RHOC","stoichiometry":10.0},{"gene":"MPHOSPH10","stoichiometry":0.2},{"gene":"AKAP8","stoichiometry":0.2},{"gene":"RAP1GDS1","stoichiometry":0.2},{"gene":"CLIP1","stoichiometry":0.2},{"gene":"STRBP","stoichiometry":0.2},{"gene":"COMMD10","stoichiometry":0.2},{"gene":"KIAA0430","stoichiometry":0.2},{"gene":"SMAP2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000609","total_profiled":1310},"omim":[{"mim_id":"621466","title":"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2KK; CMT2KK","url":"https://www.omim.org/entry/621466"},{"mim_id":"621331","title":"BRAIN SMALL VESSEL DISEASE 5 WITH OSTEOPOROSIS; BSVD5","url":"https://www.omim.org/entry/621331"},{"mim_id":"621172","title":"RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 39; ARHGEF39","url":"https://www.omim.org/entry/621172"},{"mim_id":"621092","title":"IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 3; IQGAP3","url":"https://www.omim.org/entry/621092"},{"mim_id":"620875","title":"FIC DOMAIN-CONTAINING PROTEIN ADENYLYLTRANSFERASE; FICD","url":"https://www.omim.org/entry/620875"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RHOA"},"hgnc":{"alias_symbol":["Rho12","RHOH12"],"prev_symbol":["ARH12","ARHA"]},"alphafold":{"accession":"P61586","domains":[{"cath_id":"3.40.50.300","chopping":"3-177","consensus_level":"medium","plddt":97.1075,"start":3,"end":177}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P61586","model_url":"https://alphafold.ebi.ac.uk/files/AF-P61586-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P61586-F1-predicted_aligned_error_v6.png","plddt_mean":93.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RHOA","jax_strain_url":"https://www.jax.org/strain/search?query=RHOA"},"sequence":{"accession":"P61586","fasta_url":"https://rest.uniprot.org/uniprotkb/P61586.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P61586/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P61586"}},"corpus_meta":[{"pmid":"24413737","id":"PMC_24413737","title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.","date":"2014","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24413737","citation_count":532,"is_preprint":false},{"pmid":"15501444","id":"PMC_15501444","title":"Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility.","date":"2004","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15501444","citation_count":389,"is_preprint":false},{"pmid":"10980705","id":"PMC_10980705","title":"Inhibition of RhoA by p120 catenin.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10980705","citation_count":389,"is_preprint":false},{"pmid":"26838319","id":"PMC_26838319","title":"RhoA/Rho-Kinase in the Cardiovascular System.","date":"2016","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/26838319","citation_count":370,"is_preprint":false},{"pmid":"16622418","id":"PMC_16622418","title":"Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling.","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16622418","citation_count":351,"is_preprint":false},{"pmid":"24584070","id":"PMC_24584070","title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.","date":"2014","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24584070","citation_count":317,"is_preprint":false},{"pmid":"15665004","id":"PMC_15665004","title":"RhoA/ROCK signaling regulates Sox9 expression and actin organization during chondrogenesis.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15665004","citation_count":251,"is_preprint":false},{"pmid":"12538643","id":"PMC_12538643","title":"RhoA is required for cortical retraction and rigidity during mitotic cell rounding.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12538643","citation_count":249,"is_preprint":false},{"pmid":"11162591","id":"PMC_11162591","title":"cGMP-dependent protein kinase phosphorylates and inactivates RhoA.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11162591","citation_count":189,"is_preprint":false},{"pmid":"22931484","id":"PMC_22931484","title":"From mechanical force to RhoA activation.","date":"2012","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22931484","citation_count":181,"is_preprint":false},{"pmid":"29398449","id":"PMC_29398449","title":"RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis.","date":"2018","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/29398449","citation_count":181,"is_preprint":false},{"pmid":"20668910","id":"PMC_20668910","title":"RhoA/Rho-kinase and vascular diseases: what is the link?","date":"2010","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/20668910","citation_count":141,"is_preprint":false},{"pmid":"23488932","id":"PMC_23488932","title":"RhoA, RhoB and RhoC have different roles in cancer cell migration.","date":"2013","source":"Journal of microscopy","url":"https://pubmed.ncbi.nlm.nih.gov/23488932","citation_count":139,"is_preprint":false},{"pmid":"2501657","id":"PMC_2501657","title":"Characterization and expression of the human rhoH12 gene product.","date":"1989","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2501657","citation_count":113,"is_preprint":false},{"pmid":"27551058","id":"PMC_27551058","title":"RhoA GTPase inhibition organizes contraction during epithelial morphogenesis.","date":"2016","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27551058","citation_count":112,"is_preprint":false},{"pmid":"2457862","id":"PMC_2457862","title":"Expression of the ras-related ralA, rho12 and rab genes in adult mouse tissues.","date":"1988","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2457862","citation_count":111,"is_preprint":false},{"pmid":"29088697","id":"PMC_29088697","title":"Kctd13 deletion reduces synaptic transmission via increased RhoA.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29088697","citation_count":109,"is_preprint":false},{"pmid":"14726536","id":"PMC_14726536","title":"RhoA/ROCK signaling suppresses hypertrophic chondrocyte differentiation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14726536","citation_count":108,"is_preprint":false},{"pmid":"29377108","id":"PMC_29377108","title":"Regulation of RhoA GTPase and various transcription factors in the RhoA pathway.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29377108","citation_count":107,"is_preprint":false},{"pmid":"15339978","id":"PMC_15339978","title":"Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells.","date":"2004","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/15339978","citation_count":107,"is_preprint":false},{"pmid":"21849473","id":"PMC_21849473","title":"Citron kinase controls abscission through RhoA and anillin.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21849473","citation_count":101,"is_preprint":false},{"pmid":"20004716","id":"PMC_20004716","title":"RhoA/ROCK1 signaling regulates stress granule formation and apoptosis.","date":"2009","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/20004716","citation_count":101,"is_preprint":false},{"pmid":"21264179","id":"PMC_21264179","title":"The role of RhoA/Rho kinase pathway in endothelial dysfunction.","date":"2010","source":"Journal of cardiovascular disease research","url":"https://pubmed.ncbi.nlm.nih.gov/21264179","citation_count":100,"is_preprint":false},{"pmid":"9670022","id":"PMC_9670022","title":"Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9670022","citation_count":98,"is_preprint":false},{"pmid":"31431179","id":"PMC_31431179","title":"Mechanotransduction: from the cell surface to the nucleus via RhoA.","date":"2019","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31431179","citation_count":97,"is_preprint":false},{"pmid":"15883643","id":"PMC_15883643","title":"Rac1/Cdc42 and RhoA GTPases antagonistically regulate chondrocyte proliferation, hypertrophy, and apoptosis.","date":"2005","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/15883643","citation_count":90,"is_preprint":false},{"pmid":"31907416","id":"PMC_31907416","title":"Syndecan-4 tunes cell mechanics by activating the kindlin-integrin-RhoA pathway.","date":"2020","source":"Nature materials","url":"https://pubmed.ncbi.nlm.nih.gov/31907416","citation_count":89,"is_preprint":false},{"pmid":"28518134","id":"PMC_28518134","title":"ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca2+/RhoA pathway.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/28518134","citation_count":89,"is_preprint":false},{"pmid":"27533896","id":"PMC_27533896","title":"Rac1 and RhoA: Networks, loops and bistability.","date":"2016","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/27533896","citation_count":87,"is_preprint":false},{"pmid":"26100081","id":"PMC_26100081","title":"RhoA orchestrates glycolysis for TH2 cell differentiation and allergic airway inflammation.","date":"2015","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26100081","citation_count":87,"is_preprint":false},{"pmid":"24467208","id":"PMC_24467208","title":"Regulation of RhoA activity by adhesion molecules and mechanotransduction.","date":"2014","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24467208","citation_count":85,"is_preprint":false},{"pmid":"31883774","id":"PMC_31883774","title":"RhoA Mediates Epithelial Cell Shape Changes via Mechanosensitive Endocytosis.","date":"2019","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/31883774","citation_count":84,"is_preprint":false},{"pmid":"18991642","id":"PMC_18991642","title":"RhoA/Rho-kinase as a therapeutic target in asthma.","date":"2008","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18991642","citation_count":83,"is_preprint":false},{"pmid":"35563826","id":"PMC_35563826","title":"RhoA Signaling in Neurodegenerative Diseases.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35563826","citation_count":82,"is_preprint":false},{"pmid":"11245616","id":"PMC_11245616","title":"Ca2+-RhoA signaling pathway required for polyamine-dependent intestinal epithelial cell migration.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11245616","citation_count":79,"is_preprint":false},{"pmid":"25802147","id":"PMC_25802147","title":"A RhoA Signaling Pathway Regulates Dendritic Golgi Outpost Formation.","date":"2015","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/25802147","citation_count":76,"is_preprint":false},{"pmid":"31632513","id":"PMC_31632513","title":"RhoA/ROCK pathway: implication in osteoarthritis and therapeutic targets.","date":"2019","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/31632513","citation_count":74,"is_preprint":false},{"pmid":"31105010","id":"PMC_31105010","title":"Anillin Promotes Cell Contractility by Cyclic Resetting of RhoA Residence Kinetics.","date":"2019","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/31105010","citation_count":73,"is_preprint":false},{"pmid":"26363224","id":"PMC_26363224","title":"CMKLR1 and GPR1 mediate chemerin signaling through the RhoA/ROCK pathway.","date":"2015","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26363224","citation_count":72,"is_preprint":false},{"pmid":"22986288","id":"PMC_22986288","title":"Lysophospholipid receptor activation of RhoA and lipid signaling pathways.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22986288","citation_count":70,"is_preprint":false},{"pmid":"14581471","id":"PMC_14581471","title":"RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14581471","citation_count":68,"is_preprint":false},{"pmid":"18524772","id":"PMC_18524772","title":"RhoA-GDP regulates RhoB protein stability. Potential involvement of RhoGDIalpha.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18524772","citation_count":67,"is_preprint":false},{"pmid":"21196273","id":"PMC_21196273","title":"RhoA can lead the way in tumor cell invasion and metastasis.","date":"2011","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/21196273","citation_count":61,"is_preprint":false},{"pmid":"15664190","id":"PMC_15664190","title":"RhoA GTPase regulates B cell receptor signaling.","date":"2005","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15664190","citation_count":61,"is_preprint":false},{"pmid":"17908916","id":"PMC_17908916","title":"p66Shc mediates anoikis through RhoA.","date":"2007","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17908916","citation_count":58,"is_preprint":false},{"pmid":"37353478","id":"PMC_37353478","title":"Structure of human TRPV4 in complex with GTPase RhoA.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37353478","citation_count":57,"is_preprint":false},{"pmid":"25101858","id":"PMC_25101858","title":"CD44 acts through RhoA to regulate YAP signaling.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25101858","citation_count":57,"is_preprint":false},{"pmid":"15972668","id":"PMC_15972668","title":"Integrin regulation by RhoA in thymocytes.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15972668","citation_count":56,"is_preprint":false},{"pmid":"17928627","id":"PMC_17928627","title":"Identification and characterization of RHOA-interacting proteins in bovine spermatozoa.","date":"2007","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/17928627","citation_count":56,"is_preprint":false},{"pmid":"36306821","id":"PMC_36306821","title":"A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology.","date":"2022","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36306821","citation_count":55,"is_preprint":false},{"pmid":"11276396","id":"PMC_11276396","title":"RhoA/Rho-kinase, vascular changes, and hypertension.","date":"2001","source":"Current hypertension reports","url":"https://pubmed.ncbi.nlm.nih.gov/11276396","citation_count":53,"is_preprint":false},{"pmid":"15880494","id":"PMC_15880494","title":"Prolonged lesional expression of RhoA and RhoB following spinal cord injury.","date":"2005","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15880494","citation_count":53,"is_preprint":false},{"pmid":"17661354","id":"PMC_17661354","title":"Targeting by myosin phosphatase-RhoA interacting protein mediates RhoA/ROCK regulation of myosin phosphatase.","date":"2008","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17661354","citation_count":53,"is_preprint":false},{"pmid":"32355562","id":"PMC_32355562","title":"RhoA/Rho-kinases in asthma: from pathogenesis to therapeutic targets.","date":"2020","source":"Clinical & translational immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32355562","citation_count":52,"is_preprint":false},{"pmid":"25043657","id":"PMC_25043657","title":"mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.","date":"2014","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/25043657","citation_count":50,"is_preprint":false},{"pmid":"33906663","id":"PMC_33906663","title":"RhoA: a dubious molecule in cardiac pathophysiology.","date":"2021","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/33906663","citation_count":48,"is_preprint":false},{"pmid":"29330286","id":"PMC_29330286","title":"Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration.","date":"2018","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/29330286","citation_count":44,"is_preprint":false},{"pmid":"20559774","id":"PMC_20559774","title":"Revisited and revised: is RhoA always a villain in cardiac pathophysiology?","date":"2010","source":"Journal of cardiovascular translational research","url":"https://pubmed.ncbi.nlm.nih.gov/20559774","citation_count":44,"is_preprint":false},{"pmid":"28949796","id":"PMC_28949796","title":"RhoA, RhoB and RhoC differentially regulate endothelial barrier function.","date":"2017","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/28949796","citation_count":43,"is_preprint":false},{"pmid":"29949791","id":"PMC_29949791","title":"LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29949791","citation_count":43,"is_preprint":false},{"pmid":"31156701","id":"PMC_31156701","title":"RHOA in Gastric Cancer: Functional Roles and Therapeutic Potential.","date":"2019","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31156701","citation_count":42,"is_preprint":false},{"pmid":"26556565","id":"PMC_26556565","title":"Pathophysiological effects of RhoA and Rho-associated kinase on cardiovascular system.","date":"2016","source":"Journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/26556565","citation_count":40,"is_preprint":false},{"pmid":"26146960","id":"PMC_26146960","title":"Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation.","date":"2015","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26146960","citation_count":39,"is_preprint":false},{"pmid":"20347825","id":"PMC_20347825","title":"Cytokinesis and cancer: Polo loves ROCK'n' Rho(A).","date":"2010","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/20347825","citation_count":38,"is_preprint":false},{"pmid":"28553321","id":"PMC_28553321","title":"RhoA as a target to promote neuronal survival and axon regeneration.","date":"2017","source":"Neural regeneration research","url":"https://pubmed.ncbi.nlm.nih.gov/28553321","citation_count":38,"is_preprint":false},{"pmid":"18829842","id":"PMC_18829842","title":"G protein-coupled receptors go extracellular: RhoA integrates the integrins.","date":"2008","source":"Molecular interventions","url":"https://pubmed.ncbi.nlm.nih.gov/18829842","citation_count":37,"is_preprint":false},{"pmid":"27495873","id":"PMC_27495873","title":"Silencing Drp1 inhibits glioma cells proliferation and invasion by RHOA/ ROCK1 pathway.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27495873","citation_count":37,"is_preprint":false},{"pmid":"29207169","id":"PMC_29207169","title":"Daam1 activates RhoA to regulate Wnt5a‑induced glioblastoma cell invasion.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/29207169","citation_count":36,"is_preprint":false},{"pmid":"21187285","id":"PMC_21187285","title":"Phospholipase Cdelta3 regulates RhoA/Rho kinase signaling and neurite outgrowth.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21187285","citation_count":36,"is_preprint":false},{"pmid":"27693615","id":"PMC_27693615","title":"Variegated RHOA mutations in human cancers.","date":"2016","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/27693615","citation_count":33,"is_preprint":false},{"pmid":"36658753","id":"PMC_36658753","title":"RhoA regulation in space and time.","date":"2023","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/36658753","citation_count":32,"is_preprint":false},{"pmid":"24453048","id":"PMC_24453048","title":"Genistein induces cytokinesis failure through RhoA delocalization and anaphase chromosome bridging.","date":"2014","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24453048","citation_count":32,"is_preprint":false},{"pmid":"24589508","id":"PMC_24589508","title":"Phosphorylation-mediated regulation of GEFs for RhoA.","date":"2013","source":"Cell adhesion & migration","url":"https://pubmed.ncbi.nlm.nih.gov/24589508","citation_count":30,"is_preprint":false},{"pmid":"33546351","id":"PMC_33546351","title":"Role of Small GTPase RhoA in DNA Damage Response.","date":"2021","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33546351","citation_count":29,"is_preprint":false},{"pmid":"29199510","id":"PMC_29199510","title":"Regulation of RhoA GTPase and novel target proteins for ROCK.","date":"2017","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/29199510","citation_count":29,"is_preprint":false},{"pmid":"29940159","id":"PMC_29940159","title":"RhoA regulates Schwann cell differentiation through JNK pathway.","date":"2018","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29940159","citation_count":28,"is_preprint":false},{"pmid":"35297520","id":"PMC_35297520","title":"TRPV4: A trigger of pathological RhoA activation in neurological disease.","date":"2022","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35297520","citation_count":27,"is_preprint":false},{"pmid":"14551573","id":"PMC_14551573","title":"Vasoconstriction, RhoA/Rho-kinase and the erectile response.","date":"2003","source":"International journal of impotence research","url":"https://pubmed.ncbi.nlm.nih.gov/14551573","citation_count":26,"is_preprint":false},{"pmid":"22228765","id":"PMC_22228765","title":"Protein kinase D regulates RhoA activity via rhotekin phosphorylation.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22228765","citation_count":26,"is_preprint":false},{"pmid":"19940064","id":"PMC_19940064","title":"CCK activates RhoA and Rac1 differentially through Galpha13 and Galphaq in mouse pancreatic acini.","date":"2009","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19940064","citation_count":26,"is_preprint":false},{"pmid":"37020186","id":"PMC_37020186","title":"RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling.","date":"2023","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/37020186","citation_count":25,"is_preprint":false},{"pmid":"29330353","id":"PMC_29330353","title":"Afadin and RhoA control pancreatic endocrine mass via lumen morphogenesis.","date":"2018","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/29330353","citation_count":25,"is_preprint":false},{"pmid":"30254631","id":"PMC_30254631","title":"Fam65b Phosphorylation Relieves Tonic RhoA Inhibition During T Cell Migration.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30254631","citation_count":25,"is_preprint":false},{"pmid":"33379334","id":"PMC_33379334","title":"Role of Macrophages and RhoA Pathway in Atherosclerosis.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33379334","citation_count":23,"is_preprint":false},{"pmid":"36758801","id":"PMC_36758801","title":"RhoA rescues cardiac senescence by regulating Parkin-mediated mitophagy.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36758801","citation_count":23,"is_preprint":false},{"pmid":"35106464","id":"PMC_35106464","title":"RhoA within myofibers controls satellite cell microenvironment to allow hypertrophic growth.","date":"2021","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/35106464","citation_count":23,"is_preprint":false},{"pmid":"30659117","id":"PMC_30659117","title":"Hypoxia suppresses myofibroblast differentiation by changing RhoA activity.","date":"2019","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/30659117","citation_count":22,"is_preprint":false},{"pmid":"15706042","id":"PMC_15706042","title":"RhoA and resistance artery remodeling.","date":"2005","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15706042","citation_count":22,"is_preprint":false},{"pmid":"32567555","id":"PMC_32567555","title":"CDC42 drives RHOA activity and actin polymerization during capacitation.","date":"2020","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32567555","citation_count":22,"is_preprint":false},{"pmid":"20814828","id":"PMC_20814828","title":"Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency.","date":"2010","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/20814828","citation_count":22,"is_preprint":false},{"pmid":"24949442","id":"PMC_24949442","title":"RhoA controls Wnt upregulation on microstructured titanium surfaces.","date":"2014","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/24949442","citation_count":22,"is_preprint":false},{"pmid":"27583192","id":"PMC_27583192","title":"Control of cell mechanics by RhoA and calcium fluxes during epithelial scattering.","date":"2016","source":"Tissue barriers","url":"https://pubmed.ncbi.nlm.nih.gov/27583192","citation_count":21,"is_preprint":false},{"pmid":"29410088","id":"PMC_29410088","title":"Mapping Interactions between p27 and RhoA that Stimulate Cell Migration.","date":"2018","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29410088","citation_count":21,"is_preprint":false},{"pmid":"29462287","id":"PMC_29462287","title":"Cytoskeletal Associated Filamin A and RhoA Affect Neural Progenitor Specification During Mitosis.","date":"2019","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/29462287","citation_count":21,"is_preprint":false},{"pmid":"24840563","id":"PMC_24840563","title":"Influence of ARHGEF3 and RHOA knockdown on ACTA2 and other genes in osteoblasts and osteoclasts.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24840563","citation_count":21,"is_preprint":false},{"pmid":"39122698","id":"PMC_39122698","title":"Untangling the role of RhoA in the heart: protective effect and mechanism.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39122698","citation_count":19,"is_preprint":false},{"pmid":"28032931","id":"PMC_28032931","title":"FKBP51 regulates cell motility and invasion via RhoA signaling.","date":"2017","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/28032931","citation_count":19,"is_preprint":false},{"pmid":"31964711","id":"PMC_31964711","title":"RHOA-mediated mechanical force generation through Dectin-1.","date":"2020","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/31964711","citation_count":19,"is_preprint":false},{"pmid":"33979620","id":"PMC_33979620","title":"RhoA/Cdc42 signaling drives cytoplasmic maturation but not endomitosis in megakaryocytes.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33979620","citation_count":19,"is_preprint":false},{"pmid":"22243257","id":"PMC_22243257","title":"Ameloblastin regulates cell attachment and proliferation through RhoA and p27.","date":"2011","source":"European journal of oral sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22243257","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43667,"output_tokens":10274,"usd":0.142556,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20916,"output_tokens":5699,"usd":0.123527,"stage2_stop_reason":"end_turn"},"total_usd":0.266083,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"Human rhoH12 (RHOA) protein is a ~21 kDa GTPase; amplification of normal rhoH12 in NIH 3T3 cells reduced serum dependence, increased saturation density, and conferred tumorigenicity in nude mice, establishing that elevated wild-type RHOA expression has transforming activity.\",\n      \"method\": \"Transfection/overexpression in NIH 3T3 fibroblasts, Western immunoblot, immunoprecipitation, focus/soft-agar assays, nude mouse tumorigenicity\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct overexpression with multiple phenotypic readouts in a single study, but no mechanistic pathway defined beyond protein identity\",\n      \"pmids\": [\"2501657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"p120 catenin selectively inhibits RhoA activity in vitro and in vivo; its interaction with cadherins and its inhibition of RhoA are mutually exclusive, suggesting p120 regulates RhoA recruitment at nascent cell-cell contacts.\",\n      \"method\": \"In vitro RhoA activity assay, cell-based RhoA activity assay, co-immunoprecipitation\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro activity assay plus cell-based assay with mutual exclusivity data; two orthogonal methods in a single study\",\n      \"pmids\": [\"10980705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"cGMP-dependent protein kinase (cGK) phosphorylates RhoA at Ser188 in vitro, and constitutively active cGK blocks stress fiber formation induced by LPA or constitutively active RhoA; a Ser188Ala RhoA mutant is resistant to this inhibition, and cGK expression inhibits membrane translocation of RhoA.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis (Ser188Ala), cell transfection with constitutively active cGK, actin stress fiber imaging\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro phosphorylation assay plus mutagenesis plus cell-based functional rescue in a single study\",\n      \"pmids\": [\"11162591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RhoA activity is required for polyamine-dependent intestinal epithelial cell migration; elevated intracellular Ca2+ induced by polyamines increases RhoA protein synthesis and stability, and inhibition of RhoA with C3 transferase blocks myosin II stress fiber formation and prevents cell migration.\",\n      \"method\": \"C3 transferase inhibition, RhoA activity assay, Ca2+ ionophore and chelator experiments, Western blot\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition with functional readout plus Ca2+ manipulation; single lab, two orthogonal approaches\",\n      \"pmids\": [\"11245616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"RhoA is required for cortical retraction and increased cortical rigidity during mitotic cell rounding; RhoA activity is elevated in rounded preanaphase mitotic cells, coinciding with serine/threonine phosphorylation-mediated decrease of p190RhoGAP activity; Rho-kinase mediates these RhoA effects.\",\n      \"method\": \"Dominant-negative/constitutively active RhoA expression, p190RhoGAP phosphorylation analysis, atomic force microscopy for cortical rigidity, time-lapse imaging\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (activity measurement, phosphorylation analysis, mechanical measurements) with genetic loss-of-function in single rigorous study\",\n      \"pmids\": [\"12538643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"RhoA (but not Rac or Cdc42) directly binds to the amino-terminal regulatory domain of MEKK1; this interaction requires an intact PHD domain cysteine in MEKK1; RhoA-GTP stimulates MEKK1 kinase activity toward MEK4 up to 10-fold.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis of MEKK1 PHD domain\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis plus binding assay; multiple methods in single study\",\n      \"pmids\": [\"14581471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RhoA/ROCK signaling suppresses Sox9 expression and chondrogenesis: RhoA overexpression decreases glycosaminoglycan synthesis and Sox9 levels via repression of the Sox9 promoter, while ROCK inhibition (Y27632) has opposite effects; effects on Sox9 are mediated through cortical actin reorganization.\",\n      \"method\": \"RhoA overexpression, ROCK inhibitor (Y27632) treatment, Sox9 promoter-luciferase assay, actin cytoskeleton imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter assay plus overexpression plus pharmacological inhibition, single lab\",\n      \"pmids\": [\"15665004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RhoA overexpression in chondrogenic ATDC5 cells increases proliferation, delays hypertrophic differentiation, activates cyclin D1 transcription, and represses the collagen X promoter; dominant-negative RhoA inhibits PTH-related peptide induction of cyclin D1; ROCK inhibition partially rescues RhoA overexpression effects.\",\n      \"method\": \"RhoA overexpression, dominant-negative RhoA, ROCK inhibitor Y27632, luciferase promoter assays, alkaline phosphatase and mineralization assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays and genetic constructs, single lab\",\n      \"pmids\": [\"14726536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RhoA activation downstream of podocalyxin (PC) requires NHERF and ezrin; full-length PC (but not the NHERF-binding-site mutant) increases RhoA activity and redistributes actin toward the apical membrane in MDCK cells; PC interacts directly with ezrin via its juxtamembrane cytoplasmic region.\",\n      \"method\": \"Stable cell lines expressing full-length vs. truncated PC, RhoA pulldown activity assay, immunofluorescence, co-immunoprecipitation/pulldown\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pulldown activity assay and mutant analysis, single lab, two methods\",\n      \"pmids\": [\"15339978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RhoA activation is sufficient to stimulate β1 and β2 integrin-mediated adhesion in thymocytes; loss of Rho function impairs VCAM-1 adhesion and prevents integrin activation induced by Rac-1 and Rap1A; RhoA activity is critical for integrin-mediated thymocyte migration to chemokines.\",\n      \"method\": \"Dominant-negative RhoA expression, C3 transferase inhibition, integrin adhesion assays, migration assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with multiple adhesion/migration readouts, single lab\",\n      \"pmids\": [\"15972668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RhoA activity regulates B cell receptor (BCR) signaling: BCR stimulation activates RhoA downstream of PI3K; dominant-negative RhoA and C3 toxin inhibit BCR-dependent calcium flux and cell proliferation; RhoA is required for PtdIns-4,5-P2 synthesis and PLCγ2 activation (but not PLCγ2 tyrosine phosphorylation); exogenous PtdIns-4,5-P2 restores calcium flux in RhoA-inhibited cells.\",\n      \"method\": \"Dominant-negative RhoA expression, C3 toxin, PI3K inhibitor, calcium flux assay, proliferation assay, PtdIns-4,5-P2 measurement\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple loss-of-function tools with mechanistic rescue experiment (exogenous PIP2), two orthogonal approaches\",\n      \"pmids\": [\"15664190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Synaptopodin induces actin stress fibers by competitively blocking Smurf1-mediated ubiquitination of RhoA, thereby preventing proteasomal degradation of RhoA; gene silencing of synaptopodin causes loss of stress fibers and impairs cell migration in kidney podocytes.\",\n      \"method\": \"siRNA knockdown of synaptopodin, ubiquitination assays, RhoA degradation assays, actin imaging, migration assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic ubiquitination assay plus RNAi phenotype plus rescue, multiple orthogonal methods\",\n      \"pmids\": [\"16622418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"p66Shc mediates anoikis through RhoA activation; re-expression of p66Shc in p66Shc-null cells restores anoikis through a mechanism requiring focal adhesion targeting and RhoA activation (but not cytochrome c-binding motif); this pathway stimulates focal adhesions, stress fibers, and tension-dependent cell death upon detachment.\",\n      \"method\": \"p66Shc re-expression in knockout cells, RhoA activity assay, focal adhesion imaging, cell death assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined mechanistic pathway with mutant analysis and RhoA activity measurement, single lab\",\n      \"pmids\": [\"17908916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In bovine spermatozoa, the GNA13-RhoA-ROCK2-LIMK2-cofilin signaling cascade is present; RhoA interacts with AKAP4 (identified by overlay, immunoprecipitation, and mass spectrometry); AKAP3 phosphorylation increases its interaction with PRKAR2 and ROPN1 (RhoA-interacting proteins).\",\n      \"method\": \"Western blot, overlay assay, co-immunoprecipitation, mass spectrometry, pulldown\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP and mass spectrometry for interaction identification, single lab\",\n      \"pmids\": [\"17928627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RhoA-GDP (not RhoA-GTP) regulates RhoB protein stability via a mechanism requiring RhoGDIα; RhoGDIα is rate-limiting in basal conditions, and silencing RhoA makes RhoGDI available to stabilize RhoB; a RhoA mutant (R68E) unable to bind RhoGDIα cannot rescue RhoB up-regulation after RhoA silencing.\",\n      \"method\": \"siRNA knockdown of RhoA, RhoGDIα manipulation, half-life measurement, RhoA mutant (R68E) rescue experiment, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis plus knockdown with protein stability readout, single lab, two methods\",\n      \"pmids\": [\"18524772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Myosin phosphatase-RhoA interacting protein (M-RIP) directly binds both RhoA and the myosin-binding subunit of myosin phosphatase in vitro, targets myosin phosphatase to the actomyosin contractile filament, and is required for RhoA/ROCK-mediated inhibition of myosin phosphatase; M-RIP silencing prevents LPA-mediated MYPT1 phosphorylation and inhibition of myosin phosphatase activity; M-RIP silencing leads to loss of stress fiber-associated RhoA.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding, siRNA knockdown, MYPT1 phosphorylation assay\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding plus siRNA functional assay, single lab\",\n      \"pmids\": [\"17661354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Only activated (GTP-bound) RhoA and ROCK1 are sequestered into stress granules (SGs) during cellular stress; sequestration of activated ROCK1 in SGs prevents ROCK1 from interacting with JIP-3 and activating the JNK apoptotic pathway, protecting cells from apoptosis.\",\n      \"method\": \"Immunofluorescence, co-immunoprecipitation, stress granule fractionation, apoptosis assays\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus localization with functional consequence, single lab\",\n      \"pmids\": [\"20004716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In mouse pancreatic acini, CCK activates RhoA specifically through Gα13 (not Gα12 or Gαq); the RGS domain of p115-RhoGEF (Gα12/13-specific inhibitor) abolishes CCK-stimulated RhoA activation.\",\n      \"method\": \"Constitutively active Gα subunit expression, RhoA and Rac1 activity assays, RGS domain inhibitor constructs\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — activity assays with specific pathway inhibitors and constitutively active constructs, single lab\",\n      \"pmids\": [\"19940064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PLCδ3 negatively regulates RhoA protein expression; PLCδ3 knockdown prevents the differentiation-induced decrease in RhoA protein levels in Neuro2a cells; dominant-negative RhoA or ROCK inhibitor Y27632 rescues neurite extension defects caused by PLCδ3 knockdown, placing RhoA downstream of PLCδ3 in neurite outgrowth regulation.\",\n      \"method\": \"siRNA knockdown, dominant-negative RhoA, ROCK inhibitor, Western blot, neurite outgrowth assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis via rescue experiment plus protein-level measurements, single lab\",\n      \"pmids\": [\"21187285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Citron kinase (CIT-K) acts as an upstream regulator (not downstream effector) of RhoA during late cytokinesis/abscission; CIT-K depletion displaces active RhoA and anillin from the midbody; CIT-K overexpression-induced abscission delay is reversed by RhoA inactivation; CIT-K physically interacts with anillin.\",\n      \"method\": \"CIT-K siRNA depletion, RhoA inactivation, co-immunoprecipitation (CIT-K with anillin), live-cell imaging of cytokinesis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by rescue experiment, physical interaction by co-IP, single lab\",\n      \"pmids\": [\"21849473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Protein kinase D phosphorylates rhotekin (at Ser-435), an effector of RhoA; a phosphomimetic S435E rhotekin mutant increases active RhoA levels and enhances RhoA membrane anchoring, resulting in increased stress fiber formation.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis (S435E), RhoA activity assay, immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay plus mutagenesis plus functional readout, single lab\",\n      \"pmids\": [\"22228765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The RHOA p.Gly17Val mutant found in AITL does not bind GTP and inhibits wild-type RHOA function (dominant-negative), demonstrating that this recurrent somatic mutation causes loss of RHOA GTPase activity.\",\n      \"method\": \"GTP-binding assay, dominant-negative functional assay\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct GTP-binding assay plus dominant-negative functional assay; independently replicated in two papers (PMID 24413737 and 24584070)\",\n      \"pmids\": [\"24413737\", \"24584070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CD44 acts upstream of RhoA to regulate YAP expression and nuclear localization; CD44 knockdown reduces RhoA expression; constitutively active RhoA (RhoA-V14) rescues YAP reduction caused by CD44 knockdown; RhoA knockdown similarly reduces YAP, placing RhoA between CD44 and YAP in the Hippo pathway.\",\n      \"method\": \"siRNA knockdown of CD44 and RhoA, constitutively active RhoA rescue, Western blot, nuclear localization assay\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by rescue experiment, single lab\",\n      \"pmids\": [\"25101858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Fam65b is an atypical inhibitor of RhoA that restricts spontaneous RhoA activation in resting T lymphocytes; chemokine stimulation phosphorylates Fam65b, decreasing its affinity for RhoA and causing its translocation from plasma membrane to cytosol, thereby relieving tonic RhoA inhibition and allowing RhoA-dependent actin polymerization and T cell migration.\",\n      \"method\": \"Fam65b-deficient mouse (conditional KO), RhoA activity assay, phosphorylation analysis, intranodal migration imaging, in vitro migration assay\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO mouse with RhoA activity measurements plus phosphorylation analysis, single lab\",\n      \"pmids\": [\"30254631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RhoA deficiency in T cells inhibits TH2 (but not TH1) differentiation, prevents allergic airway inflammation, and causes defects in glycolysis and oxidative phosphorylation; RhoA couples glycolysis to TH2 differentiation through regulation of IL-4 receptor mRNA expression and TH2-specific signaling; ROCK inhibition also blocks TH2 differentiation.\",\n      \"method\": \"Conditional RhoA knockout mice (RhoA flox/flox × CD2-Cre), metabolic assay (Seahorse XF24), cytokine measurement (ELISA, intracellular staining), in vivo allergy model\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with multiple mechanistic readouts, single lab\",\n      \"pmids\": [\"26100081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RhoA GTPase controls Golgi outpost (GOP) formation in dendrites via a RhoA-ROCK-LIMK1-PKD1-slingshot-cofilin-dynamin pathway that regulates tubule fission from the somatic Golgi; live-cell imaging demonstrated that GOPs are generated from somatic GA tubules, and perturbation of RhoA pathway arrests tubule fission.\",\n      \"method\": \"Live-cell imaging, confocal microscopy, pharmacological inhibition of pathway components, dominant-negative and constitutively active constructs\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live imaging plus pathway dissection with multiple inhibitors, single lab\",\n      \"pmids\": [\"25802147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In Drosophila apical constriction, a RhoA GAP (C-GAP) spatially restricts RhoA pathway activity to a central apical cortex position and is required for pulsatile actomyosin contractility; C-GAP coordinates with RhoGEF2 to drive RhoA activity cycling underlying contractile pulses; C-GAP expression level governs the transition from reversible to irreversible cell shape change.\",\n      \"method\": \"Genetic loss-of-function (C-GAP mutants), live imaging, FRET-based RhoA biosensor, epistasis analysis with RhoGEF2\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biosensor-based activity measurements plus genetic epistasis with live imaging, multiple orthogonal methods\",\n      \"pmids\": [\"27551058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Deletion of Kctd13 in mice elevates RhoA protein levels (consistent with KCTD13/CUL3 ubiquitin ligase targeting RhoA for degradation) and reduces synaptic transmission; pharmacological inhibition of RhoA reverses the reduced synaptic transmission phenotype.\",\n      \"method\": \"Kctd13 gene deletion (mouse KO), RhoA protein level measurement, synaptic transmission electrophysiology, RhoA inhibitor rescue\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with mechanistic rescue (RhoA inhibition reverses phenotype), RhoA protein level measurement; replicated in zebrafish\",\n      \"pmids\": [\"29088697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Daam1 activates RhoA downstream of Wnt5a to promote glioblastoma cell invasion; siRNA knockdown of Daam1 inhibits Wnt5a-induced RhoA activation and stress fiber formation; RhoA inhibitor (CCG-1423) also blocks Wnt5a-induced invasion, placing Daam1 upstream of RhoA in Wnt5a→Daam1→RhoA→invasion pathway.\",\n      \"method\": \"siRNA knockdown, pulldown assays for Daam1 and RhoA activation, cell invasion assay, RhoA inhibitor\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis by dual knockdown and inhibitor, RhoA activity assays, single lab\",\n      \"pmids\": [\"29207169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RhoA promotes Schwann cell differentiation via the JNK pathway rather than ROCK; inhibition of RhoA (with C3 transferase or siRNA) activates JNK and p38 MAPK in differentiating Schwann cells; JNK inhibitor (but not p38 inhibitor) rescues SC differentiation under RhoA inhibition.\",\n      \"method\": \"siRNA knockdown, C3 transferase inhibition, ROCK inhibitor (no effect), JNK/p38 inhibitors, differentiation assays\",\n      \"journal\": \"Experimental neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis via pathway-selective inhibitors plus knockdown, single lab\",\n      \"pmids\": [\"29940159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FKBP51 promotes RhoA activity and ROCK signaling by interacting with RhoGAPs DLC1 and DLC2 (identified by immunoprecipitation and mass spectrometry); FKBP51 overexpression increases RhoA activity and invasion, while FKBP51 depletion causes cortical actin redistribution and decreases RhoA activity and cell motility.\",\n      \"method\": \"Immunoprecipitation + mass spectrometry, RhoA activity assay, siRNA knockdown, overexpression, actin imaging\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS-validated interaction plus RhoA activity assay with loss- and gain-of-function, single lab\",\n      \"pmids\": [\"28032931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RHOA G17V expression in CD4+ T cells induces T follicular helper (Tfh) cell specification with increased ICOS upregulation and PI3K/MAPK signaling; combined with Tet2 loss, RHOA G17V drives AITL development in mice; in vivo tumor proliferation is inhibited by ICOS/PI3K-specific blockade.\",\n      \"method\": \"Transgenic/conditional expression of Rhoa G17V in CD4+ T cells, Tet2 KO/RHOA G17V double-mutant mouse model, ICOS/PI3K inhibitor treatment, flow cytometry\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo mouse model with genetic interaction (epistasis), pathway inhibitor rescue; multiple orthogonal methods\",\n      \"pmids\": [\"29398449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Anillin directly binds GTP-RhoA at the cortical membrane to antagonize its otherwise labile membrane association, promoting effector recruitment; anillin also concentrates membrane PIP2 to retain RhoA after it disengages from anillin; cyclic re-binding of RhoA to anillin (regulated by anillin cortical density) repeatedly resets RhoA dissociation kinetics ('kinetic scaffolding'), substantially increasing RhoA dwell time.\",\n      \"method\": \"FRAP, live-cell imaging, optogenetics, mutant analysis (anillin-RhoA binding mutants), PIP2 manipulation\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple biophysical methods (FRAP, optogenetics) with mutant validation; mechanistic model tested experimentally\",\n      \"pmids\": [\"31105010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Optogenetic activation of RhoA in model epithelium shows: short pulses drive reversible junction contractions; longer pulses produce irreversible junction length changes; junction remodeling requires formin-mediated E-cadherin clustering and dynamin-dependent endocytosis downstream of RhoA; irreversible deformation involves thresholded tension remodeling and continuous strain relaxation.\",\n      \"method\": \"Optogenetics (pulsatile RhoA activation), live imaging, dynamin inhibitor, formin inhibitor, vertex model\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — optogenetic control with quantitative modeling and pharmacological dissection; multiple orthogonal methods\",\n      \"pmids\": [\"31883774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ARHGAP29 induction under hypoxia suppresses RhoA activity and MRTF-A signaling, reversing myofibroblast differentiation; decreased RhoA activity under hypoxia is causally linked to reduced αSMA expression and altered contractility.\",\n      \"method\": \"Hypoxia treatment, ARHGAP29 induction measurement, RhoA activity assay, MRTF-A localization, siRNA knockdown, actin imaging\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — activity assay plus knockdown with mechanistic link to transcription factor, single lab\",\n      \"pmids\": [\"30659117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Dectin-1 stimulation by β-glucan activates RHOA downstream of SRC family kinases (SFK, not SYK) to drive ROCK-myosin light chain (MLC) pathway, generating mechanical force/areal contraction and mediating phagocytosis of C. albicans.\",\n      \"method\": \"RHOA activity assay, SYK and SFK inhibitors, traction force microscopy, phagocytosis assay, stress fiber imaging\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — activity assay plus pathway-specific inhibitors plus functional phagocytosis assay, single lab\",\n      \"pmids\": [\"31964711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Tension on syndecan-4 activates the kindlin-2/β1 integrin/RhoA axis in a PI3K-dependent manner to tune cell mechanics; syndecan-4 cytoplasmic variable region is indispensable for mechanical adaptation; a syndecan-4/α-actinin/F-actin scaffold assembles at the bead adhesion site.\",\n      \"method\": \"Magnetic twisting cytometry (local tension application), RhoA activity assay (GLISA), PI3K inhibitor, β1 integrin knockdown, kindlin-2 knockdown, YAP activation measurement\",\n      \"journal\": \"Nature materials\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal mechanistic assays (force application, activity assay, pathway knockdowns) with mechanistic model validated experimentally\",\n      \"pmids\": [\"31907416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CDC42 drives RHOA activation during sperm capacitation; RHOA activation and its effect on actin polymerization begin when CDC42 reaches maximum activity; RHOA's role in capacitation and acrosomal reaction is independent of ROCK1.\",\n      \"method\": \"CDC42/RHOA inhibitors, ROCK1 inhibitor, actin polymerization kinetics assay, capacitation assay, acrosome reaction assay\",\n      \"journal\": \"Reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological epistasis plus activity assays, single lab\",\n      \"pmids\": [\"32567555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RhoA/Cdc42 signaling is dispensable for megakaryocyte polyploidization (endomitosis) but is essential for cytoplasmic maturation and proplatelet formation; RhoA/Cdc42 double KO causes macrothrombocytopenia; the maturation defect is associated with downregulation of MLC2 and β1-tubulin, upregulation of LIMK1 and cofilin-1, and impaired MKL1/SRF signaling.\",\n      \"method\": \"Conditional RhoA/Cdc42 double-KO mice, bone marrow analyses, protein/mRNA profiling, proplatelet formation assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional double-KO with defined molecular mechanism (MKL1/SRF), multiple orthogonal readouts in single rigorous study\",\n      \"pmids\": [\"33979620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cardiomyocyte-specific RhoA KO mice develop dilated cardiomyopathy and enhanced senescence with impaired mitophagy; RhoA-ROCK phosphorylates N-Myc leading to its degradation and Parkin upregulation; loss of RhoA reduces Parkin, impairing mitophagy; re-expression of Parkin in RhoA-depleted cardiomyocytes rescues mitophagy and cardiac function in vitro and in vivo.\",\n      \"method\": \"Cardiomyocyte-specific RhoA conditional KO mouse, Parkin re-expression rescue, N-Myc phosphorylation analysis, mitophagy assay, cardiac function measurement (echocardiography)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with mechanistic rescue experiment (Parkin re-expression), phosphorylation analysis; multiple orthogonal methods\",\n      \"pmids\": [\"36758801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Human TRPV4 forms a direct structural complex with RhoA, with RhoA interacting with the membrane-facing surface of TRPV4 ankyrin repeat domains; contact interface residues are mutated in neuropathies; RhoA suppresses TRPV4 channel activity; agonist (4α-PDD) causes pore opening while inhibitor (HC-067047) induces a π-to-α transition in the pore-forming helix S6.\",\n      \"method\": \"Cryo-EM structure of TRPV4-RhoA complex, functional channel assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure with defined binding interface, functionally validated by channel activity assays\",\n      \"pmids\": [\"37353478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Conditional deletion of RhoA in osteoclast lineage causes osteopetrosis due to suppressed bone resorption; RhoA deficiency suppresses Akt-mTOR-NFATc1 signaling during osteoclast differentiation; RhoA activation in osteoclast precursors prevented OVX-induced bone loss in mice.\",\n      \"method\": \"Osteoclast-specific RhoA conditional KO mice, OVX model, bone marrow macrophage differentiation assay, Akt/mTOR/NFATc1 pathway analysis\",\n      \"journal\": \"Molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with in vivo phenotype and pathway identification, single lab\",\n      \"pmids\": [\"37020186\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RHOA is a plasma-membrane-associated small GTPase that cycles between inactive GDP-bound (cytosolic, complexed with RhoGDI) and active GTP-bound (membrane-localized) states regulated by GEFs (including NET1, Ect2, RhoGEF2, Daam1), GAPs (including p190RhoGAP, C-GAP, ARHGAP29, DLC1/DLC2), GDIs, and post-translational modifications (Ser188 phosphorylation by PKA/cGK inactivates RhoA and promotes cytosolic sequestration; Tyr42 phosphorylation and Cys16/20 oxidation promote GDI dissociation); once active, RhoA drives actomyosin contractility through its principal effector ROCK (which phosphorylates MLC and inhibits myosin phosphatase via MYPT1), regulates actin polymerization and stress fiber formation, controls cytokinesis/abscission, mitotic cell rounding, epithelial junction remodeling, dendritic Golgi outpost biogenesis, Schwann cell differentiation (via JNK), B-cell receptor signaling (via PIP2/PLCγ2), TH2 differentiation (via ICOS/PI3K and glycolysis), osteoclast differentiation (via Akt-mTOR-NFATc1), cardiac mitochondrial quality control (via ROCK-N-Myc-Parkin axis), and transcriptional programs (via SRF/MRTF-A and YAP/TAZ); upstream, RHOA is activated by GPCRs (through Gα12/13), mechanical force (via integrins, syndecan-4, and cadherins), and CDC42, while being inhibited by p120 catenin, Smurf1-mediated ubiquitination (counteracted by synaptopodin), Fam65b (relieved by chemokine-induced phosphorylation), and KCTD13/CUL3 ubiquitin ligase; structurally, RhoA directly contacts TRPV4 ankyrin repeat domains (suppressing channel activity) and binds MEKK1 to stimulate its kinase activity, revealing roles beyond cytoskeletal regulation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RHOA is a ~21 kDa small GTPase that cycles between inactive GDP-bound and active GTP-bound states to control actomyosin contractility, cell shape, and motility across diverse cell types [#0, #4]. In its active form it engages effectors to drive stress fiber and focal adhesion formation, mitotic cortical rigidity and rounding, and tension-dependent processes; its principal contractile output runs through ROCK, which sustains myosin light-chain phosphorylation by inhibiting myosin phosphatase via the scaffold M-RIP that targets the phosphatase to actomyosin filaments [#4, #15]. Active RHOA membrane residence is stabilized at the cortex by anillin, which binds GTP-RHOA and concentrates PIP2 to repeatedly reset its dissociation kinetics ('kinetic scaffolding'), a mechanism critical for cortical effector recruitment and cytokinesis/abscission, where citron kinase acts upstream to maintain active RHOA and anillin at the midbody [#32, #19]. RHOA activity is set by an extensive regulatory network: it is activated downstream of GPCRs through Gα13 and of receptors and mechanical inputs including CD44, syndecan-4/integrin/kindlin-2, podocalyxin, Dectin-1, Wnt5a-Daam1, and CDC42 [#17, #36, #22, #8, #35, #28, #37], and is restrained by GAPs (C-GAP, ARHGAP29, and DLC1/2 acting through FKBP51), by p120 catenin, by the atypical inhibitor Fam65b, and by ubiquitin-mediated degradation via Smurf1 (countered by synaptopodin) and the KCTD13/CUL3 ligase [#26, #34, #30, #1, #23, #11, #27]. Phosphorylation of RHOA at Ser188 by cGMP-dependent kinase inactivates it and blocks its membrane translocation [#2]. Beyond cytoskeletal regulation, RHOA directly binds and stimulates the kinase MEKK1, contacts the TRPV4 ankyrin-repeat domain to suppress channel activity, and governs transcriptional programs through MRTF-A/SRF and the Hippo effector YAP [#5, #40, #38, #22]. Through these activities RHOA shapes specialized cellular programs including B-cell receptor signaling via PIP2/PLCγ2, TH2 differentiation, osteoclast differentiation via Akt-mTOR-NFATc1, cardiac mitochondrial quality control via a ROCK-N-Myc-Parkin axis, Schwann cell differentiation via JNK, and dendritic Golgi outpost biogenesis [#10, #24, #41, #39, #29, #25]. The recurrent somatic RHOA p.Gly17Val mutation, which abolishes GTP binding and acts dominant-negatively, drives angioimmunoblastic T-cell lymphoma by inducing T follicular helper specification through ICOS/PI3K signaling, particularly in cooperation with Tet2 loss [#21, #31].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Established that RHOA is a ~21 kDa GTPase whose elevated wild-type expression is transforming, motivating mechanistic study of its signaling outputs.\",\n      \"evidence\": \"Overexpression in NIH 3T3 fibroblasts with focus/soft-agar and nude mouse tumorigenicity assays\",\n      \"pmids\": [\"2501657\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No downstream pathway defined beyond protein identity\", \"Mechanism of transformation not resolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined how RHOA is switched off post-translationally, showing cGMP-dependent kinase phosphorylates Ser188 to block stress fiber formation and membrane translocation.\",\n      \"evidence\": \"In vitro kinase assay, Ser188Ala mutagenesis, and actin imaging in cells\",\n      \"pmids\": [\"11162591\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address how this integrates with GEF/GAP regulation in vivo\", \"Tissue contexts where this dominates unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed RHOA drives mitotic cortical rigidity and rounding through ROCK and downregulation of p190RhoGAP, linking RHOA activity to cell-cycle-coupled mechanics.\",\n      \"evidence\": \"Dominant-negative/CA RhoA, p190RhoGAP phosphorylation analysis, atomic force microscopy, time-lapse imaging\",\n      \"pmids\": [\"12538643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GEF responsible for mitotic RhoA activation not identified here\", \"How phosphorylation suppresses p190RhoGAP unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Revealed a non-cytoskeletal effector function: RHOA-GTP directly binds and stimulates MEKK1 kinase activity, connecting RHOA to MAPK signaling.\",\n      \"evidence\": \"Co-IP, in vitro kinase assay toward MEK4, and MEKK1 PHD-domain mutagenesis\",\n      \"pmids\": [\"14581471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts for RhoA-MEKK1 coupling not established\", \"Selectivity over Rac/Cdc42 in cells not tested in vivo\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Connected RHOA to immune-receptor signaling, demonstrating it is required downstream of PI3K for BCR-driven PIP2 synthesis, PLCγ2 activation, and calcium flux.\",\n      \"evidence\": \"Dominant-negative RhoA, C3 toxin, PI3K inhibition, calcium flux, and exogenous PIP2 rescue\",\n      \"pmids\": [\"15664190\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The effector linking RhoA to PIP2 synthesis not identified\", \"GEF activating RhoA downstream of BCR unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified ubiquitin-dependent control of RHOA abundance, showing synaptopodin stabilizes RhoA by blocking Smurf1-mediated ubiquitination to maintain stress fibers.\",\n      \"evidence\": \"siRNA knockdown, ubiquitination and degradation assays, actin/migration phenotypes in podocytes\",\n      \"pmids\": [\"16622418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Smurf1 selectively targets active vs inactive RhoA not resolved\", \"Generality beyond podocytes untested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Clarified how RHOA-effector coupling to myosin phosphatase is organized in space, identifying M-RIP as a scaffold targeting myosin phosphatase to actomyosin for RhoA/ROCK-mediated inhibition.\",\n      \"evidence\": \"Co-IP, in vitro binding, siRNA knockdown, MYPT1 phosphorylation assay\",\n      \"pmids\": [\"17661354\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of M-RIP binding both RhoA and MYPT1 not defined\", \"In vivo requirement not shown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established RHOA as a disease driver, showing the recurrent AITL p.Gly17Val mutant fails to bind GTP and acts dominant-negatively.\",\n      \"evidence\": \"GTP-binding and dominant-negative functional assays; replicated across two studies\",\n      \"pmids\": [\"24413737\", \"24584070\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequences of dominant-negative RhoA in T cells not yet defined here\", \"Why a loss-of-function GTPase mutant is oncogenic unresolved at this stage\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed how RHOA activity is spatially patterned to produce pulsatile contractility, with a GAP (C-GAP) restricting RhoA pathway activity and coordinating with RhoGEF2 to drive activity cycling during apical constriction.\",\n      \"evidence\": \"Drosophila genetic loss-of-function, FRET RhoA biosensor, live imaging, epistasis with RhoGEF2\",\n      \"pmids\": [\"27551058\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular trigger initiating each pulse not defined\", \"How GEF/GAP activities are temporally synchronized unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated in vivo that RHOA abundance is controlled by the KCTD13/CUL3 ligase, and that excess RhoA impairs synaptic transmission reversibly by RhoA inhibition.\",\n      \"evidence\": \"Kctd13 KO mouse, RhoA protein measurement, electrophysiology, RhoA-inhibitor rescue; replicated in zebrafish\",\n      \"pmids\": [\"29088697\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ubiquitination of RhoA by KCTD13/CUL3 inferred, not shown biochemically here\", \"Effector pathway altering synaptic transmission not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved the oncogenic mechanism of RHOA G17V, showing it induces Tfh specification via ICOS/PI3K and cooperates with Tet2 loss to drive AITL in vivo.\",\n      \"evidence\": \"Conditional Rhoa G17V expression, Tet2/G17V double-mutant mice, ICOS/PI3K inhibitor treatment, flow cytometry\",\n      \"pmids\": [\"29398449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a GTP-binding-deficient mutant activates ICOS/PI3K mechanistically unclear\", \"Contribution of dominant-negative versus neomorphic activity not separated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the biophysical basis of RHOA cortical residence, showing anillin binds GTP-RhoA and concentrates PIP2 to repeatedly reset its dissociation kinetics ('kinetic scaffolding').\",\n      \"evidence\": \"FRAP, optogenetics, anillin-RhoA binding mutants, PIP2 manipulation\",\n      \"pmids\": [\"31105010\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How anillin density is regulated in vivo not addressed\", \"Generality across non-cytokinetic contexts untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Quantitatively linked RHOA activity dynamics to junction remodeling, showing pulse duration determines reversible versus irreversible deformation via formin-mediated E-cadherin clustering and dynamin endocytosis.\",\n      \"evidence\": \"Optogenetic pulsatile RhoA activation, live imaging, formin/dynamin inhibitors, vertex modeling\",\n      \"pmids\": [\"31883774\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous GEF/GAP dynamics producing such pulses not mapped\", \"Molecular memory underlying irreversibility incompletely defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed RHOA integrates mechanical force, identifying a syndecan-4/kindlin-2/β1 integrin/RhoA axis that tunes cell mechanics in a PI3K-dependent manner.\",\n      \"evidence\": \"Magnetic twisting cytometry, RhoA GLISA, PI3K inhibition, integrin/kindlin-2 knockdowns, YAP readout\",\n      \"pmids\": [\"31907416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GEF converting tension into RhoA activation not identified\", \"Coupling between RhoA and YAP downstream not mechanistically detailed here\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Separated RHOA's roles in a developmental program, showing RhoA/Cdc42 are dispensable for megakaryocyte polyploidization but essential for cytoplasmic maturation and proplatelet formation via MKL1/SRF.\",\n      \"evidence\": \"Conditional RhoA/Cdc42 double-KO mice, protein/mRNA profiling, proplatelet assays\",\n      \"pmids\": [\"33979620\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contribution of RhoA versus Cdc42 not separated\", \"Direct SRF target genes driving maturation not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided a structural view of a non-canonical RHOA function, showing direct binding to the TRPV4 ankyrin-repeat domain that suppresses channel activity, with interface residues mutated in neuropathies.\",\n      \"evidence\": \"Cryo-EM structure of the TRPV4-RhoA complex and channel functional assays\",\n      \"pmids\": [\"37353478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GDP/GTP state governs the interaction not fully resolved\", \"Physiological signaling consequence of channel suppression in neurons untested here\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended RHOA function to organelle quality control, defining a cardiomyocyte RhoA-ROCK-N-Myc-Parkin axis required for mitophagy and cardiac function.\",\n      \"evidence\": \"Cardiomyocyte-specific RhoA KO, Parkin re-expression rescue, N-Myc phosphorylation analysis, mitophagy and echocardiography\",\n      \"pmids\": [\"36758801\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct N-Myc phosphorylation by ROCK not biochemically isolated\", \"Whether this axis operates in non-cardiac tissues unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the full GEF/GAP/GDI network, post-translational modifications, and degradation pathways are integrated to produce the precise spatiotemporal RhoA activity patterns required by each cellular program remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unified model linking upstream activators to context-specific effector choice (ROCK vs JNK vs MEKK1)\", \"How loss-of-function G17V produces gain-of-function oncogenic phenotypes mechanistically unclear\", \"Endogenous activity dynamics in most tissues not measured with biosensors\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [0, 21]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [4, 17, 22, 36]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 40]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 20, 32]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [23, 16]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [4, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [17, 22, 36]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [4, 19]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 24, 31]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [21, 31]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [25, 38, 41]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ROCK\", \"MEKK1\", \"TRPV4\", \"anillin\", \"RhoGDI\", \"M-RIP\", \"rhotekin\", \"Fam65b\"],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}